Clinical trial · Interventional
Post-treatment Care of Breast Cancer Survivors
NCT00821288CI-TRIAL-00028168completedN/AClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
The overall goal of this proposal is to improve the post-treatment care of breast cancer survivors and to understand the barriers to optimal post-treatment care in Latina and Non-Hispanic women.
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Breast Neoplasm | Breast Neoplasm | ONTOLOGY_EXACT | 0.98 |
Interventions
Interventions (2)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Facing Forward | Behavioral | — | UNRESOLVED |
| Survivorship Intervention | Behavioral | — | UNRESOLVED |
Design
Arms and outcomes
Arms (2)
- type
- EXPERIMENTAL
- label
- Survivorship Intervention
- description
- Latina and Caucasian breast cancer survivors treated in an urban academic medical center receiving Survivorship Intervention
- interventionNames
- Behavioral: Survivorship Intervention
- type
- ACTIVE_COMPARATOR
- label
- Facing Forward
- description
- Latina and Caucasian breast cancer survivors treated in an urban academic medical center receiving Survivorship Intervention Facing Forward: Life after Cancer Treatment manual
- interventionNames
- Behavioral: Facing Forward
Primary outcomes (1)
- measure
- Change in FACIT-TS questionnaire score
Eligibility
Eligibility (as posted)
- Sex
- Female
- Minimum age
- 18 Years
Show eligibility criteria text
Inclusion Criteria: * Participants will be screened for the following inclusion criteria: * Age \>18 years * History of stage 0, I, II, or IIIa breast cancer and no evidence of recurrent disease * Within 6 weeks of completion of breast cancer therapy (Surgery, Radiation or Chemotherapy) * Caucasian and/or Hispanic (English or Spanish-speaking) * Willing to undergo a 1 hr cancer survivorship evaluation Exclusion Criteria: * Patients with the following active conditions or behaviors will be excluded from participation: * Evidence of recurrent or metastatic breast cancer * Patients who have received surgery only with no adjuvant therapy * Uncontrolled or significant psychiatric illness/social situations that would preclude completion of questionnaire or follow-up evaluation.
References
Publications (1)
- DERIVEDHershman DL, Greenlee H, Awad D, Kalinsky K, Maurer M, Kranwinkel G, Brafman L, Jayasena R, Tsai WY, Neugut AI, Crew KD. Randomized controlled trial of a clinic-based survivorship intervention following adjuvant therapy in breast cancer survivors. Breast Cancer Res Treat. 2013 Apr;138(3):795-806. doi: 10.1007/s10549-013-2486-1. Epub 2013 Mar 31. PMID 23542954